Yahoo Web Search

Sign In

  1. Also Try

Search results

  1. www.abbvie.com.sg › our-company › abbvie-in-singaporeAbbVie In Singapore - Our Company | AbbVie

    Contact Us. AbbVie Pte Ltd (Regional & Commercial Operations) 9 North Buona Vista Drive #19-01. The Metropolis Tower One. Singapore 138588. Tel: +65 6715 8100. AbbVie Operations Singapore Pte Ltd (Manufacturing Operations) 23 Tuas South Avenue 6. Singapore 637022.

  2. news.abbvie.com › 2024/01/26-AbbVie-Expands-Biologics-Manufacturing-CapacityAbbVie Expands Biologics Manufacturing Capacity with a $223...

    Jan 25, 2024 · This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie's global network. Located in Singapore's Tuas Biomedical Park, AbbVie's Singapore plant is a state-of-the-art small-molecule and biologics manufacturing facility serving markets worldwide.

  3. sbr.com.sg › healthcare › more-newsBiopharmaceutical company AbbVie acquires manufacturing site in ...

    Nov 21, 2014 · Reflecting progress from AbbVie's announcement for manufacturing investment in Asia earlier this year, AbbVie Inc. has acquired a small molecule active pharmaceutical ingredient (API) manufacturing site in Singapore's Tuas Biomedical Park.

  4. www.todayonline.com › business › us-drugmaker-abbvie-opens-first-asian-plant-sporeUS drugmaker AbbVie opens first Asian plant in S’pore - TODAY

    Sep 30, 2016 · SINGAPORE — New York-listed biopharmaceutical firm AbbVie yesterday opened the first phase of its US$320 million (S$436 million) manufacturing plant in Singapore, which will help the firm make...

  5. headlines.businessnewsasia.com › 20240126-abbvie-invests-223m-in-singapore-toAbbVie Invests $223m in Singapore to Expand Biologics...

    Jan 26, 2024 · New York-listed AbbVie strengthened its manufacturing capabilities by breaking ground on a new $223 million expansion of its Singapore manufacturing facility. This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie’s global network.

  6. www.asiaone.com › business › abbvie-expands-biologics-manufacturing-capacity-223AbbVie Expands Biologics Manufacturing Capacity with a $223 ... -...

    Jan 26, 2024 · Once completed, the new expansion will add new biologics manufacturing capacity to AbbVie's global network and more than 100 new jobs in Singapore. Located in Singapore's Tuas Biomedical Park...

  7. www.healthcareasia.org › 2024 › abbvie-expands-biologics-manufacturing-inAbbVie expands biologics manufacturing in Singapore

    Jan 30, 2024 · AbbVie, a US pharmaceutical company, is investing $223 million in expanding its manufacturing facility in Singapore’s Tuas Biomedical Park. This expansion is expected to create over 100 jobs and increase biologics manufacturing capacity by 24,000 liters.

  8. finance.yahoo.com › news › abbvie-expands-biologics-manufacturing-capacityAbbVie Expands Biologics Manufacturing Capacity with a $223...

    Jan 26, 2024 · Located in Singapore's Tuas Biomedical Park, AbbVie's Singapore plant is a state-of-the-art small-molecule and biologics manufacturing facility serving markets worldwide.

  9. www.fiercepharma.com › manufacturing › abbvie-opens-first-phase-320m-site-singaporeAbbVie opens first phase of $320M site in Singapore

    Sep 29, 2016 · AbbVie in 2014 announced its plans to build the 120,000-square-meter (1.2 million-square-foot) site in the Tuas Biomedical Park in Singapore, its first facility in Asia.

  10. www.edb.gov.sg › content › damPRESS RELEASE

    Located in Singapore's Tuas Biomedical Park, AbbVie's Singapore plant is a state-of-the-art small-molecule and biologics manufacturing facility serving markets worldwide.